• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射后,埃弗米星(SCH 27899)在小鼠、大鼠、兔子和食蟹猴体内的药代动力学。

Pharmacokinetics of an everninomicin (SCH 27899) in mice, rats, rabbits, and cynomolgus monkeys following intravenous administration.

作者信息

Lin C, Gupta S, Loebenberg D, Cayen M N

机构信息

Department of Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA.

出版信息

Antimicrob Agents Chemother. 2000 Apr;44(4):916-9. doi: 10.1128/AAC.44.4.916-919.2000.

DOI:10.1128/AAC.44.4.916-919.2000
PMID:10722491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC89792/
Abstract

The pharmacokinetics of SCH 27899, a novel oligosaccharide compound of the everninomicin class with excellent activity against gram-positive strains, was studied with mice, rats, rabbits, and cynomolgus monkeys following intravenous administration as SCH 27899-N-methylglucamine-hydroxypropyl beta-cyclodextrin. Concentrations of SCH 27899 in mouse serum, rat plasma, and rabbit serum were determined by a high-pressure liquid chromatography method on a poly(styrene-divinyl benzene) column, and those in monkey plasma were determined by a paired-ion chromatographic method. Plasma and serum concentrations of SCH 27899 exhibited a biexponential decline in all species following intravenous administration. The half-lives at beta phase were 3.0 to 7.9 h in mice, rats, and rabbits and 24 h in cynomolgus monkeys. There was a linear relationship between the area under the curve extrapolated to infinity [AUC(I)] in mice and dose. Rabbits also exhibited dose proportionality in AUC(I). However, in rats, increasing the dose from 3 to 60 mg/kg of body weight resulted in a 49-fold increase in AUC(I). When the species was changed from mouse to rat, rabbit, or cynomolgus monkey, AUC(I) increased, whereas clearance (CL) decreased. It was concluded that the pharmacokinetics of SCH 27899 in animals varied with species; CL was the highest in mice and rats, followed by rabbits and cynomolgus monkeys.

摘要

SCH 27899是一种新的寡糖化合物,属于埃弗米星类,对革兰氏阳性菌株具有优异活性。以SCH 27899-N-甲基葡糖胺-羟丙基β-环糊精的形式对小鼠、大鼠、兔子和食蟹猴进行静脉给药后,研究了其药代动力学。采用高压液相色谱法在聚(苯乙烯-二乙烯基苯)柱上测定小鼠血清、大鼠血浆和兔子血清中SCH 27899的浓度,采用配对离子色谱法测定猴血浆中SCH 27899的浓度。静脉给药后,所有物种的血浆和血清中SCH 27899浓度均呈双指数下降。小鼠、大鼠和兔子β相的半衰期为3.0至7.9小时,食蟹猴为24小时。小鼠曲线下面积外推至无穷大[AUC(I)]与剂量之间呈线性关系。兔子的AUC(I)也呈剂量比例关系。然而,在大鼠中,将体重剂量从3毫克/千克增加到60毫克/千克会导致AUC(I)增加49倍。当物种从小鼠变为大鼠、兔子或食蟹猴时,AUC(I)增加,而清除率(CL)降低。得出结论,SCH 27899在动物中的药代动力学因物种而异;CL在小鼠和大鼠中最高,其次是兔子和食蟹猴。

相似文献

1
Pharmacokinetics of an everninomicin (SCH 27899) in mice, rats, rabbits, and cynomolgus monkeys following intravenous administration.静脉注射后,埃弗米星(SCH 27899)在小鼠、大鼠、兔子和食蟹猴体内的药代动力学。
Antimicrob Agents Chemother. 2000 Apr;44(4):916-9. doi: 10.1128/AAC.44.4.916-919.2000.
2
Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys.新型唑类广谱抗真菌药SCH 56592在小鼠、大鼠、兔子、狗和食蟹猴体内的药代动力学
Antimicrob Agents Chemother. 2000 Mar;44(3):727-31. doi: 10.1128/AAC.44.3.727-731.2000.
3
Comparative pharmacokinetics of Sch 28191 and amphotericin B in mice, rats, dogs, and cynomolgus monkeys.Sch 28191与两性霉素B在小鼠、大鼠、犬和食蟹猴体内的比较药代动力学。
Antimicrob Agents Chemother. 1984 Oct;26(4):446-9. doi: 10.1128/AAC.26.4.446.
4
Pharmacokinetic studies of CP-74,667, a new quinolone, in laboratory animals.新型喹诺酮类药物CP-74,667在实验动物中的药代动力学研究。
Antimicrob Agents Chemother. 1992 Aug;36(8):1671-6. doi: 10.1128/AAC.36.8.1671.
5
High-performance liquid chromatographic analysis of the anti-tumor agent SCH 66336 in cynomolgus monkey plasma and evaluation of its chiral inversion in animals.
J Chromatogr B Biomed Sci Appl. 1999 May 14;728(1):133-41. doi: 10.1016/s0378-4347(99)00070-5.
6
Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.卡芦莫南和氨曲南在小鼠、大鼠、家兔、犬及食蟹猴体内的比较药代动力学。
Antimicrob Agents Chemother. 1986 Jan;29(1):127-34. doi: 10.1128/AAC.29.1.127.
7
Pharmacokinetic studies and renal dehydropeptidase stability of the new beta-lactamase inhibitor BRL 42715 in animals.新型β-内酰胺酶抑制剂BRL 42715在动物体内的药代动力学研究及肾脱氢肽酶稳定性
Antimicrob Agents Chemother. 1991 Sep;35(9):1748-52. doi: 10.1128/AAC.35.9.1748.
8
Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans.贝西沙星对兔、猴和人进行局部给药后的眼药代动力学。
J Ocul Pharmacol Ther. 2009 Aug;25(4):335-44. doi: 10.1089/jop.2008.0116.
9
Simple and sensitive high-performance liquid chromatographic method for the determination of an everninomycin, SCH 27899, in rat plasma.
J Chromatogr B Biomed Sci Appl. 1999 Jun 25;730(1):55-9. doi: 10.1016/s0378-4347(99)00204-2.
10
Pharmacokinetics and metabolism of [14C]viramidine in rats and cynomolgus monkeys.[14C]替诺福韦酯在大鼠和食蟹猴体内的药代动力学及代谢
Antimicrob Agents Chemother. 2003 Aug;47(8):2458-63. doi: 10.1128/AAC.47.8.2458-2463.2003.

引用本文的文献

1
Allometric scaling of xenobiotic clearance: uncertainty versus universality.异生物清除的异速生长缩放:不确定性与普遍性
AAPS PharmSci. 2001;3(4):E29. doi: 10.1208/ps030429.
2
An ATP-binding cassette transporter and two rRNA methyltransferases are involved in resistance to avilamycin in the producer organism Streptomyces viridochromogenes Tü57.一种ATP结合盒转运蛋白和两种rRNA甲基转移酶参与了产抗生素的绿色产色链霉菌Tü57对阿维拉霉素的抗性。
Antimicrob Agents Chemother. 2001 Mar;45(3):690-5. doi: 10.1128/AAC.45.3.690-695.2001.

本文引用的文献

1
Microbiological characterization of everninomicins B and D.埃弗米霉素B和D的微生物学特性
Antimicrob Agents Chemother. 1974 Sep;6(3):232-8. doi: 10.1128/AAC.6.3.232.
2
EVERNINOMICIN, A NEW ANTIBIOTIC COMPLEX FROM MICROMONOSPORA CARBONACEA.埃弗米霉素,一种来自碳霉素小单孢菌的新型抗生素复合物。
Antimicrob Agents Chemother (Bethesda). 1964;10:24-32.
3
Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum.SCH 27899(一种具有广泛革兰氏阳性菌谱的埃弗霉素类寡糖)的抗菌活性
Clin Microbiol Infect. 1995 Sep;1(1):35-43. doi: 10.1111/j.1469-0691.1995.tb00022.x.
4
Simple and sensitive high-performance liquid chromatographic method for the determination of an everninomycin, SCH 27899, in rat plasma.
J Chromatogr B Biomed Sci Appl. 1999 Jun 25;730(1):55-9. doi: 10.1016/s0378-4347(99)00204-2.
5
Increasing problems in the therapy of enterococcal infections.肠球菌感染治疗中日益增多的问题。
Eur J Clin Microbiol Infect Dis. 1993 Jun;12(6):409-12. doi: 10.1007/BF01967433.
6
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers.对来自美国12家医疗中心的多重耐药粪肠球菌的评估与特性分析。
J Clin Microbiol. 1994 Nov;32(11):2840-2. doi: 10.1128/jcm.32.11.2840-2842.1994.
7
Emerging multiply resistant enterococci among clinical isolates. II. Validation of the etest to recognize glycopeptide-resistant strains.
Diagn Microbiol Infect Dis. 1995 Feb;21(2):95-100. doi: 10.1016/0732-8893(94)00146-n.
8
Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group.临床分离株中出现的多重耐药肠球菌。一、美国97个医学中心监测研究的患病率数据。肠球菌研究组。
Diagn Microbiol Infect Dis. 1995 Feb;21(2):85-93. doi: 10.1016/0732-8893(94)00147-o.
9
Purification and biological studies of everninomicin B.埃弗米霉素B的纯化及生物学研究。
Antimicrob Agents Chemother (Bethesda). 1965;5:821-7.
10
Animal scale-up.动物放大
J Pharmacokinet Biopharm. 1973 Oct;1(5):435-61. doi: 10.1007/BF01059667.